학술논문
The burden of prostate cancer in North Africa and Middle East, 1990–2019: Findings from the global burden of disease study
Document Type
article
Author
Mohsen Abbasi-Kangevari; Sahar Saeedi Moghaddam; Seyyed-Hadi Ghamari; Mohammadreza Azangou-Khyavy; Mohammad-Reza Malekpour; Negar Rezaei; Nazila Rezaei; Ali-Asghar Kolahi; GBD 2019 NAME Prostate Cancer Collaborators; Erfan Amini; Ali H. Mokdad; Hamidreza Jamshidi; Mohsen Naghavi; Bagher Larijani; Farshad Farzadfar; Behzad Abbasi; Hassan Abidi; Eman Abu-Gharbieh; Muhammad Sohail Afzal; Araz Ramazan Ahmad; Sajjad Ahmad; Ali Ahmadi; Sepideh Ahmadi; Haroon Ahmed; Mostafa Akbarzadeh-Khiavi; Hamed Akhavizadegan; Hanadi Al Hamad; Fadwa Alhalaiqa Naji Alhalaiqa; Yousef Alimohamadi; Syed Mohamed Aljunid; Omar Almidani; Jalal Arabloo; Morteza Arab-Zozani; Seyyed Shamsadin Athari; Sina Azadnajafabad; Amirhossein Azari Jafari; Nayereh Baghcheghi; Nader Bagheri; Sara Bagherieh; Abdul-Monim Mohammad Batiha; Akshaya Srikanth Bhagavathula; Ali Bijani; Nadeem Shafique Butt; Reza Darvishi Cheshmeh Soltani; Ahmad Daryani; Mostafa Dianatinasab; Iman El Sayed; Muhammed Elhadi; Ali Fatehizadeh; Masood Fereidoonnezhad; Masoud Foroutan; Maryam Gholamalizadeh; Pouya Goleij; Mohamad Golitaleb; Mohammed Ibrahim Mohialdeen Gubari; Nima Hafezi-Nejad; Arvin Haj-Mirzaian; Samer Hamidi; Shafiul Haque; Khezar Hayat; Mohammad-Salar Hosseini; Mowafa Househ; Elham Jamshidi; Amirreza Javadi Mamaghani; Farahnaz Joukar; Ali Kabir; Rohollah Kalhor; Amirali Karimi; Yousef Saleh Khader; Javad Khanali; Behzad Kiani; Hamid Reza Koohestani; Somayeh Livani; Farzan Madadizadeh; Ahmad R. Mafi; Ata Mahmoodpoor; Keivan Majidzadeh-A; Reza Malekzadeh; Ahmad Azam Malik; Fariborz Mansour-Ghanaei; Seyed Farzad Maroufi; Entezar Mehrabi Nasab; Seyyedmohammadsadeq Mirmoeeni; Yousef Mohammad; Esmaeil Mohammadi; Saeed Mohammadi; Abdollah Mohammadian-Hafshejani; Sara Momtazmanesh; Rahmatollah Moradzadeh; Paula Moraga; Mohammadreza Naghipour; Zuhair S. Natto; Seyed Aria Nejadghaderi; Maryam Noori; Ali Nowroozi; Hassan Okati-Aliabad; Reza Pakzad; Zahra Zahid Piracha; Faheem Hyder Pottoo; Alireza Rafiei; Vahid Rahmanian; Mahsa Rashidi; Mohammad-Mahdi Rashidi; Mohammad Sadegh Razeghinia; Mohsen Rezaeian; Umar Saeed; Maryam Sahebazzamani; Amirhossein Sahebkar; Abdallah M. Samy; Muhammad Arif Nadeem Saqib; Brijesh Sathian; Sadaf G. Sepanlou; Saeed Shahabi; Masood Ali Shaikh; Sara Sheikhbahaei; Reza Shirkoohi; Parnian Shobeiri; Muhammad Suleman; Amir Tiyuri; Irfan Ullah; Faezeh Vakhshiteh; Sahel Valadan Tahbaz; Seyed Hossein Yahyazadeh Jabbari; Fereshteh Yazdanpanah; Deniz Yuce; Mazyar Zahir; Maryam Zamanian; Iman Zare; Mohammad Zoladl
Source
Frontiers in Oncology, Vol 12 (2022)
Subject
Language
English
ISSN
2234-943X
Abstract
BackgroundProstate cancer (PCa) is the second most prevalent cancer among men worldwide. This study presents estimates of PCa prevalence, incidence, death, years-of-life-lost (YLLs), years-lived-with-disability (YLDs), disability-adjusted-life-years (DALYs), and the burden attributable to smoking during 1990-2019 in North Africa and Middle East using data of Global Burden of Diseases (GBD) Study 2019.MethodsThis study is a part of GBD 2019. Using vital registration and cancer registry data, the estimates on PCa burden were modeled. Risk factor analysis was performed through the six-step conceptual framework of Comparative Risk Assessment.ResultsThe age-standardized rates (95% UI) of PCa incidence, prevalence, and death in 2019 were 23.7 (18.5-27.9), 161.1 (126.6-187.6), and 11.7 (9.4-13.9) per 100,000 population. While PCa incidence and prevalence increased by 77% and 144% during 1990-2019, respectively, the death rate stagnated. Of the 397% increase in PCa new cases, 234% was due to a rise in the age-specific incidence rate, 79% due to population growth, and 84% due to population aging. The YLLs, YLDs, and DALYs of PCa increased by 2% (-11.8-23.1), 108% (75.5-155.1), and 6% (-8.9-28.1). The death rate and DALYs rate attributable to smoking have decreased 12% and 10%, respectively. The DALYs rate attributable to smoking was 37.4 (15.9-67.8) in Lebanon and 5.9 (2.5-10.6) in Saudi Arabia, which were the highest and lowest in the region, respectively.ConclusionsThe PCa incidence and prevalence rates increased during 1990-2019; however, the death rate stagnated. The increase in the incidence was mostly due to the rise in the age-specific incidence rate, rather than population growth or aging. The burden of PCa attributable to smoking has decreased in the past 30 years.